Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6606 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-09-24 (malaysiasun.com)
Holtec CEO lauds PM Modi's vision to support India's clean energy goals
Prime Minister Narendra Modi roundtable meeting with CEOs of global technology and energy companies in New York has sparked significant discussions on India
Read more
2021-04-22 (proactiveinvestors.co.uk)
FTSE 100 perks up, as ECB sticks with stimulus measures and US jobless claims beat forecasts
The UK blue chip index shows some life while US investors are expected to pause to catch their breath
Read more
2016-10-12 (nature.com)
Biosimilars in IBD: from theory to practice
Biologic agents have revolutionized the management of IBD and biosimilars (copy versions of the originator agents) are emerging as an alternative. This Review outlines the concept of biosimilars and their adoption in gastroenterology, their current use and future challenges. Biologic agents have
Read more
(nationalezorggids.nl)
Bruins is negotiating a reimbursement arrangement for MS drug Fampyra
In recent weeks, Minister Bruins of Medical Care has had a number of discussions with Biogen, the manufacturer of the MS drug Fampyra. The outcome is that Biogen sets up a reimbursement scheme in which patients can - retroactively - immediately receive a significant part of the purchase costs of the medicine Fampyra back from Biogen through a declaration. Bruins informed the House of Representatives of this yesterday, the government reports.
Read more